Completed PHASE3 INTERVENTIONAL 4-arm NCT00203645

Minimal and Brief Treatments for Pathological Gamblers

Minimal and Brief Treatments for Pathological Gamblers: Developing Effective Treatment Systems

Sponsor: Canadian Institutes of Health Research (CIHR)

Updated 5 times since 2017 Last updated: Feb 13, 2009 Started: Jul 31, 2003 Primary completion: Apr 30, 2006 Completion: Feb 28, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00203645, this PHASE3 trial focuses on Pathological Gambling and remains completed. Sponsored by Canadian Institutes of Health Research (CIHR), it has been updated 5 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Institutes of Health Research (CIHR)
University of Calgary

Data source: University of Calgary

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Calgary, Canada